Fulcrum Therapeutics, Inc. (FULC)
Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company. The firm develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015 and is headquartered in Cambridge, MA.
Address
26 LANDSDOWNE STREET
CAMBRIDGE, MA 02139
Founded
2015
Number of Employees
76
Website
http://www.fulcrumtx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)